Our data also demonstrate that immRNA‐loaded RBCEVs promoted CD8+ T cell responses to tumour antigens accompanied by Th1 polarization and tumour‐specific CTL activity in the metastatic tumour model. The gene discussed is CD8A; the disease is metastatic neoplasm.